Conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: A single center experience
Objective: The aim of this study is to determine safety and feasibility of conscious sedation using dexmedetomidine for transcatheter atrial septal defect (ASD) device closure. Material and Methods: A retrospective institutional review of transcatheter ASD device closure without endotracheal intubat...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Annals of Cardiac Anaesthesia |
Subjects: | |
Online Access: | http://www.annals.in/article.asp?issn=0971-9784;year=2016;volume=19;issue=3;spage=463;epage=467;aulast=Desai |
id |
doaj-13800386d66142c3b56021f4cc01c105 |
---|---|
record_format |
Article |
spelling |
doaj-13800386d66142c3b56021f4cc01c1052020-11-25T02:29:19ZengWolters Kluwer Medknow PublicationsAnnals of Cardiac Anaesthesia0971-97842016-01-0119346346710.4103/0971-9784.185528Conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: A single center experiencePushkar Mahendra DesaiSanjeeta R UmbarkarManjula S SarkarRishi LohiyaObjective: The aim of this study is to determine safety and feasibility of conscious sedation using dexmedetomidine for transcatheter atrial septal defect (ASD) device closure. Material and Methods: A retrospective institutional review of transcatheter ASD device closure without endotracheal intubation over 18 months. The protocol included topical oropharyngeal anesthesia using lignocaine followed by dexmedetomidine bolus 1 μg/kg intravenously over 10 min and maintenance dose 0.2-0.7 μg/kg/h. Ramsay sedation score 2-3 was maintained. Patients were analyzed regarding demographic profile, device size, procedure time, anesthesia time, recovery time, hospital stay, and any hemodynamic or procedural complications. Results: A total of 43 patients with mean age 31.56 ± 13.74 years (range: 12-56 years) were analyzed. Mean anesthesia duration was 71.75 + 21.08 min. Mean recovery time was 7.6 ± 3.01 min. 16 females and one male patient required additional propofol with a mean dose of 30.8 ± 10.49 mg. No hemodynamic instability was noted. No patient required general anesthesia with endotracheal intubation. The procedure was successful in 93.02% of patients. Four patients developed atrial fibrillation. All patients were satisfied. Conclusion: Conscious sedation using dexmedetomidine is a safe and effective anesthetic technique for percutaneous ASD closure.http://www.annals.in/article.asp?issn=0971-9784;year=2016;volume=19;issue=3;spage=463;epage=467;aulast=DesaiAmplatzer device; Atrial septal defect; Dexmedetomidine; Sedation; Transcatheter |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pushkar Mahendra Desai Sanjeeta R Umbarkar Manjula S Sarkar Rishi Lohiya |
spellingShingle |
Pushkar Mahendra Desai Sanjeeta R Umbarkar Manjula S Sarkar Rishi Lohiya Conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: A single center experience Annals of Cardiac Anaesthesia Amplatzer device; Atrial septal defect; Dexmedetomidine; Sedation; Transcatheter |
author_facet |
Pushkar Mahendra Desai Sanjeeta R Umbarkar Manjula S Sarkar Rishi Lohiya |
author_sort |
Pushkar Mahendra Desai |
title |
Conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: A single center experience |
title_short |
Conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: A single center experience |
title_full |
Conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: A single center experience |
title_fullStr |
Conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: A single center experience |
title_full_unstemmed |
Conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: A single center experience |
title_sort |
conscious sedation using dexmedetomidine for percutaneous transcatheter closure of atrial septal defects: a single center experience |
publisher |
Wolters Kluwer Medknow Publications |
series |
Annals of Cardiac Anaesthesia |
issn |
0971-9784 |
publishDate |
2016-01-01 |
description |
Objective: The aim of this study is to determine safety and feasibility of conscious sedation using dexmedetomidine for transcatheter atrial septal defect (ASD) device closure. Material and Methods: A retrospective institutional review of transcatheter ASD device closure without endotracheal intubation over 18 months. The protocol included topical oropharyngeal anesthesia using lignocaine followed by dexmedetomidine bolus 1 μg/kg intravenously over 10 min and maintenance dose 0.2-0.7 μg/kg/h. Ramsay sedation score 2-3 was maintained. Patients were analyzed regarding demographic profile, device size, procedure time, anesthesia time, recovery time, hospital stay, and any hemodynamic or procedural complications. Results: A total of 43 patients with mean age 31.56 ± 13.74 years (range: 12-56 years) were analyzed. Mean anesthesia duration was 71.75 + 21.08 min. Mean recovery time was 7.6 ± 3.01 min. 16 females and one male patient required additional propofol with a mean dose of 30.8 ± 10.49 mg. No hemodynamic instability was noted. No patient required general anesthesia with endotracheal intubation. The procedure was successful in 93.02% of patients. Four patients developed atrial fibrillation. All patients were satisfied. Conclusion: Conscious sedation using dexmedetomidine is a safe and effective anesthetic technique for percutaneous ASD closure. |
topic |
Amplatzer device; Atrial septal defect; Dexmedetomidine; Sedation; Transcatheter |
url |
http://www.annals.in/article.asp?issn=0971-9784;year=2016;volume=19;issue=3;spage=463;epage=467;aulast=Desai |
work_keys_str_mv |
AT pushkarmahendradesai conscioussedationusingdexmedetomidineforpercutaneoustranscatheterclosureofatrialseptaldefectsasinglecenterexperience AT sanjeetarumbarkar conscioussedationusingdexmedetomidineforpercutaneoustranscatheterclosureofatrialseptaldefectsasinglecenterexperience AT manjulassarkar conscioussedationusingdexmedetomidineforpercutaneoustranscatheterclosureofatrialseptaldefectsasinglecenterexperience AT rishilohiya conscioussedationusingdexmedetomidineforpercutaneoustranscatheterclosureofatrialseptaldefectsasinglecenterexperience |
_version_ |
1724833731945955328 |